October 6, 2021
RFA-CA-21-040 - Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
National Cancer Institute (NCI)
This Notice corrects the Instructions for the Submission of Multi-Component Applications in Funding Opportunity Announcement (FOA) RFA-CA-21-040, "Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)".
The following section of the FOA has been revised:
Currently Reads:
Section IV. Application and Submission Information
2. Content and Form of Application Submission
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.
The application should consist of the following components:
Modified to Read (changes shown in bold italics):
Section IV. Application and Submission Information
2. Content and Form of Application Submission
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.
The application should consist of the following components:
All other aspects of RFA-CA-21-040 remain unchanged.
Scientific/Research Contact(s)
Michael Graham Espey, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7619
Email: SP@nih.gov
Jeffrey Buchsbaum, M.D., Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5690
Email: jeff.buchsbaum@nih.gov
Bhadrasain (Vik) Vikram, M.D.
National Cancer Institute (NCI)
Telephone: 240-276-5690
Email: vikramb@mail.nih.gov
Peer Review Contact(s)
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov